Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Short-term Investments (2016 - 2025)

Rockwell Medical's Short-term Investments history spans 16 years, with the latest figure at $14.3 million for Q4 2025.

  • For Q4 2025, Short-term Investments rose 140.51% year-over-year to $14.3 million; the TTM value through Dec 2025 reached $14.3 million, up 140.51%, while the annual FY2025 figure was $14.3 million, 140.51% up from the prior year.
  • Short-term Investments reached $14.3 million in Q4 2025 per RMTI's latest filing, up from $10.1 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $14.6 million in Q3 2022 to a low of $2.0 million in Q4 2023.
  • Average Short-term Investments over 5 years is $7.8 million, with a median of $5.9 million recorded in 2023.
  • Peak YoY movement for Short-term Investments: tumbled 82.86% in 2023, then skyrocketed 204.3% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $9.2 million in 2021, then grew by 24.37% to $11.4 million in 2022, then crashed by 82.86% to $2.0 million in 2023, then surged by 204.3% to $5.9 million in 2024, then skyrocketed by 140.51% to $14.3 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Short-term Investments are $14.3 million (Q4 2025), $10.1 million (Q3 2025), and $5.9 million (Q2 2025).